Allakos Inc (ALLK)

Nov 20, 2024

Allakos Reports Q3 2024 Results and Research Progress - TipRanks

Nov 20, 2024

Nov 20, 2024

All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy - MSN

Nov 20, 2024

Nov 19, 2024

Allakos Inc. finalizes early lease termination, incurring $2.5 million in costs - Investing.com Canada

Nov 19, 2024

Nov 18, 2024

Allakos Inc. Alters Lease Agreement for Cost Savings - TipRanks

Nov 18, 2024

Nov 13, 2024

FMR LLC's Strategic Acquisition of Allakos Inc Shares - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Allakos's SWOT analysis: biotech firm's stock faces hurdles in CSU market - Investing.com

Nov 12, 2024

Nov 11, 2024

FY2024 EPS Estimates for Allakos Raised by Leerink Partnrs - MarketBeat

Nov 11, 2024

Nov 07, 2024

Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha

Nov 07, 2024

Nov 06, 2024

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 06, 2024

Nov 04, 2024

Allakos perks up after early-stage data for lead asset - MSN

Nov 04, 2024

Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Nov 04, 2024

Oct 28, 2024

Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat

Oct 28, 2024

Oct 22, 2024

3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St

Oct 22, 2024

Oct 22, 2024

Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St

Oct 22, 2024

Oct 21, 2024

Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR

Oct 21, 2024

Oct 17, 2024

The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Oct 17, 2024

Oct 17, 2024

Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World

Oct 17, 2024

Oct 16, 2024

Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR

Oct 16, 2024

Oct 15, 2024

Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR

Oct 15, 2024

Oct 14, 2024

Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily

Oct 14, 2024

Oct 14, 2024

Allakos Inc (ALLK)’s stock price range in the last year - US Post News

Oct 14, 2024

Oct 14, 2024

Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex

Oct 14, 2024

Oct 12, 2024

Allakos shares hold rating after trial update By Investing.com - Investing.com Australia

Oct 12, 2024

Oct 12, 2024

Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia

Oct 12, 2024

Oct 11, 2024

TD Cowen Reiterates Hold Rating on Allakos Inc. (ALLK) - StreetInsider.com

Oct 11, 2024

Oct 11, 2024

Piper Sandler maintains Overweight rating on Allakos shares - Investing.com India

Oct 11, 2024

Oct 11, 2024

Allakos shares hold rating after trial update - Investing.com

Oct 11, 2024

Oct 11, 2024

Allakos stock gains on trial data for lead drug (NASDAQ:ALLK) - Seeking Alpha

Oct 11, 2024

Oct 11, 2024

Piper Sandler Reiterates Overweight Rating on Allakos Inc. (ALLK) - StreetInsider.com

Oct 11, 2024

Oct 10, 2024

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - ForexTV.com

Oct 10, 2024

Oct 10, 2024

Allakos reports positive results from AK006 Phase 1 study - Investing.com India

Oct 10, 2024

Oct 10, 2024

Allakos Progress Update on AK006 and Future Milestones - TipRanks

Oct 10, 2024

Oct 10, 2024

Allakos reports positive results from AK006 Phase 1 study By Investing.com - Investing.com UK

Oct 10, 2024

Oct 10, 2024

Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - StreetInsider.com

Oct 10, 2024

Oct 08, 2024

SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World

Oct 08, 2024

Sep 30, 2024

Vernal Keratoconjunctivitis Market to Show Remarkable Growth - openPR

Sep 30, 2024

Sep 30, 2024

Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc - Barchart

Sep 30, 2024

Sep 29, 2024

Duff & Phelps Investment Management Co. Cuts Holdings in Enbridge Inc. (NYSE:ENB) - Defense World

Sep 29, 2024

Sep 28, 2024

Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions - MSN

Sep 28, 2024

Sep 27, 2024

Wall Street SWOT: Allakos stock faces pivotal year as AK006 data looms - Investing.com

Sep 27, 2024

Sep 26, 2024

Allakos (NASDAQ:ALLK) Receives Market Outperform Rating from JMP Securities - MarketBeat

Sep 26, 2024

Sep 23, 2024

Leerink Partners analysts initates a Market perform rating for Align Technology, Inc. (ALGN) - Knox Daily

Sep 23, 2024

Sep 23, 2024

Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's

Sep 23, 2024

Sep 23, 2024

French InsurTech Alan raises $193m to bolster tech and growth in Belgium - FinTech Global

Sep 23, 2024

Sep 23, 2024

Allied Properties Real Estate Investment Trust (TSE:AP.UN) Price Target Increased to C$18.50 by Analysts at Canaccord Genuity Group - MarketBeat

Sep 23, 2024

Sep 23, 2024

Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - MarketBeat

Sep 23, 2024

Sep 23, 2024

Allogene Therapeutics Inc [ALLO] Stock bought by Insider Douglas Earl Martin for $78844.0 - Knox Daily

Sep 23, 2024

Sep 23, 2024

Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down to $11.43 - Defense World

Sep 23, 2024

Sep 23, 2024

Investing in Alta Equipment Group Inc (ALTG): What You Must Know - Knox Daily

Sep 23, 2024

Sep 23, 2024

Allegion Stock: Is ALLE Outperforming The Industrials Sector? - Barchart

Sep 23, 2024